Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock

Jeffrey Kline, Peggy C. Maiorano, J. David Schroeder, Robert M. Grattan, Thomas C. Vary, John A. Watts

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

This study was designed to test the hypothesis that activation of myocardial pyruvate dehydrogenase (PDH) would improve recovery of heart function after brief, severe hemorrhagic shock. Pentobarbital-anesthetized rats were instrumented to monitor arterial blood pressure and right ventricular pressures. Rats were hemorrhaged via femoral artery to 25-30 mmHg mean arterial pressure (MAP) for 60 min, followed by retransfusion of shed blood with either 1.0 cc saline with no dichloroacetate (-DCA) or 1.0 cc saline containing 150 mg/kg sodium dichloroacetate (+DCA). Rats were observed for 3 h after retransfusion. Hearts were freeze-clamped in situ for analysis of adenosine triphosphate (ATP), creatine phosphate (CrP), lactate and pyruvate content as well as PDH activity (PDHa) and total PDH activity (PDHt). Three h after retransfusion, the rate pressure product (RPP = HR x PSP) was 23,000 ± 2733 with no DCA treatment v 362,769 mmHg/min with DCA treatment (P <0.05, ANOVA). Treatment with DCA also increased myocardial tissue content of high energy phosphates (ATP = 10.1 ± 1.1 and CrP = 5.8 ± 1.O μmol/g weight -DCA, v 15.1 ± 0.9 and 14.7 ± 1.0 μmol/g dry weight +DCA, P <0.05, both measurements). DCA administration also significantly reduced myocardial lactate contents (14.6 ± 2.7 μmol/g dry weight-DCA v 5.9 ± 1.0 +DCA). Hemorrhagic shock did not change PDHa or PDHt compared to hearts obtained during the pre-hemorrhage period. Retransfusion with DCA significantly increased PDHa activity (6.8 ± 1.1 μmol/g dry weight/min -DCA v 29.7 ± 2.0 μmol/g dry weight/min +DCA). PDHt was not different between controls and DCA-treated groups. These data indicate that activation of myocardial PDH by adding DCA to retransfused blood improved heart function and metabolism after severe hemorrhagic shock.

Original languageEnglish (US)
Pages (from-to)2465-2474
Number of pages10
JournalJournal of Molecular and Cellular Cardiology
Volume29
Issue number9
DOIs
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Hemorrhagic Shock
Pyruvic Acid
Oxidoreductases
Weights and Measures
Phosphocreatine
Lactic Acid
Arterial Pressure
Dichloroacetic Acid
Adenosine Triphosphate
Recovery of Function
Ventricular Pressure
Pentobarbital
Femoral Artery
Analysis of Variance
Phosphates
Hemorrhage
Pressure

Keywords

  • DCA
  • Dichloroacetate
  • Energy metabolism
  • Hemorrhage
  • Hemorrhagic shock
  • Lactic acid
  • PDH
  • Pyruvate dehydrogenase
  • Resuscitation
  • Shock

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock. / Kline, Jeffrey; Maiorano, Peggy C.; Schroeder, J. David; Grattan, Robert M.; Vary, Thomas C.; Watts, John A.

In: Journal of Molecular and Cellular Cardiology, Vol. 29, No. 9, 09.1997, p. 2465-2474.

Research output: Contribution to journalArticle

Kline, Jeffrey ; Maiorano, Peggy C. ; Schroeder, J. David ; Grattan, Robert M. ; Vary, Thomas C. ; Watts, John A. / Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock. In: Journal of Molecular and Cellular Cardiology. 1997 ; Vol. 29, No. 9. pp. 2465-2474.
@article{765acc26533341c093f7dbd036563adf,
title = "Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock",
abstract = "This study was designed to test the hypothesis that activation of myocardial pyruvate dehydrogenase (PDH) would improve recovery of heart function after brief, severe hemorrhagic shock. Pentobarbital-anesthetized rats were instrumented to monitor arterial blood pressure and right ventricular pressures. Rats were hemorrhaged via femoral artery to 25-30 mmHg mean arterial pressure (MAP) for 60 min, followed by retransfusion of shed blood with either 1.0 cc saline with no dichloroacetate (-DCA) or 1.0 cc saline containing 150 mg/kg sodium dichloroacetate (+DCA). Rats were observed for 3 h after retransfusion. Hearts were freeze-clamped in situ for analysis of adenosine triphosphate (ATP), creatine phosphate (CrP), lactate and pyruvate content as well as PDH activity (PDHa) and total PDH activity (PDHt). Three h after retransfusion, the rate pressure product (RPP = HR x PSP) was 23,000 ± 2733 with no DCA treatment v 362,769 mmHg/min with DCA treatment (P <0.05, ANOVA). Treatment with DCA also increased myocardial tissue content of high energy phosphates (ATP = 10.1 ± 1.1 and CrP = 5.8 ± 1.O μmol/g weight -DCA, v 15.1 ± 0.9 and 14.7 ± 1.0 μmol/g dry weight +DCA, P <0.05, both measurements). DCA administration also significantly reduced myocardial lactate contents (14.6 ± 2.7 μmol/g dry weight-DCA v 5.9 ± 1.0 +DCA). Hemorrhagic shock did not change PDHa or PDHt compared to hearts obtained during the pre-hemorrhage period. Retransfusion with DCA significantly increased PDHa activity (6.8 ± 1.1 μmol/g dry weight/min -DCA v 29.7 ± 2.0 μmol/g dry weight/min +DCA). PDHt was not different between controls and DCA-treated groups. These data indicate that activation of myocardial PDH by adding DCA to retransfused blood improved heart function and metabolism after severe hemorrhagic shock.",
keywords = "DCA, Dichloroacetate, Energy metabolism, Hemorrhage, Hemorrhagic shock, Lactic acid, PDH, Pyruvate dehydrogenase, Resuscitation, Shock",
author = "Jeffrey Kline and Maiorano, {Peggy C.} and Schroeder, {J. David} and Grattan, {Robert M.} and Vary, {Thomas C.} and Watts, {John A.}",
year = "1997",
month = "9",
doi = "10.1006/jmcc.1997.0483",
language = "English (US)",
volume = "29",
pages = "2465--2474",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "9",

}

TY - JOUR

T1 - Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock

AU - Kline, Jeffrey

AU - Maiorano, Peggy C.

AU - Schroeder, J. David

AU - Grattan, Robert M.

AU - Vary, Thomas C.

AU - Watts, John A.

PY - 1997/9

Y1 - 1997/9

N2 - This study was designed to test the hypothesis that activation of myocardial pyruvate dehydrogenase (PDH) would improve recovery of heart function after brief, severe hemorrhagic shock. Pentobarbital-anesthetized rats were instrumented to monitor arterial blood pressure and right ventricular pressures. Rats were hemorrhaged via femoral artery to 25-30 mmHg mean arterial pressure (MAP) for 60 min, followed by retransfusion of shed blood with either 1.0 cc saline with no dichloroacetate (-DCA) or 1.0 cc saline containing 150 mg/kg sodium dichloroacetate (+DCA). Rats were observed for 3 h after retransfusion. Hearts were freeze-clamped in situ for analysis of adenosine triphosphate (ATP), creatine phosphate (CrP), lactate and pyruvate content as well as PDH activity (PDHa) and total PDH activity (PDHt). Three h after retransfusion, the rate pressure product (RPP = HR x PSP) was 23,000 ± 2733 with no DCA treatment v 362,769 mmHg/min with DCA treatment (P <0.05, ANOVA). Treatment with DCA also increased myocardial tissue content of high energy phosphates (ATP = 10.1 ± 1.1 and CrP = 5.8 ± 1.O μmol/g weight -DCA, v 15.1 ± 0.9 and 14.7 ± 1.0 μmol/g dry weight +DCA, P <0.05, both measurements). DCA administration also significantly reduced myocardial lactate contents (14.6 ± 2.7 μmol/g dry weight-DCA v 5.9 ± 1.0 +DCA). Hemorrhagic shock did not change PDHa or PDHt compared to hearts obtained during the pre-hemorrhage period. Retransfusion with DCA significantly increased PDHa activity (6.8 ± 1.1 μmol/g dry weight/min -DCA v 29.7 ± 2.0 μmol/g dry weight/min +DCA). PDHt was not different between controls and DCA-treated groups. These data indicate that activation of myocardial PDH by adding DCA to retransfused blood improved heart function and metabolism after severe hemorrhagic shock.

AB - This study was designed to test the hypothesis that activation of myocardial pyruvate dehydrogenase (PDH) would improve recovery of heart function after brief, severe hemorrhagic shock. Pentobarbital-anesthetized rats were instrumented to monitor arterial blood pressure and right ventricular pressures. Rats were hemorrhaged via femoral artery to 25-30 mmHg mean arterial pressure (MAP) for 60 min, followed by retransfusion of shed blood with either 1.0 cc saline with no dichloroacetate (-DCA) or 1.0 cc saline containing 150 mg/kg sodium dichloroacetate (+DCA). Rats were observed for 3 h after retransfusion. Hearts were freeze-clamped in situ for analysis of adenosine triphosphate (ATP), creatine phosphate (CrP), lactate and pyruvate content as well as PDH activity (PDHa) and total PDH activity (PDHt). Three h after retransfusion, the rate pressure product (RPP = HR x PSP) was 23,000 ± 2733 with no DCA treatment v 362,769 mmHg/min with DCA treatment (P <0.05, ANOVA). Treatment with DCA also increased myocardial tissue content of high energy phosphates (ATP = 10.1 ± 1.1 and CrP = 5.8 ± 1.O μmol/g weight -DCA, v 15.1 ± 0.9 and 14.7 ± 1.0 μmol/g dry weight +DCA, P <0.05, both measurements). DCA administration also significantly reduced myocardial lactate contents (14.6 ± 2.7 μmol/g dry weight-DCA v 5.9 ± 1.0 +DCA). Hemorrhagic shock did not change PDHa or PDHt compared to hearts obtained during the pre-hemorrhage period. Retransfusion with DCA significantly increased PDHa activity (6.8 ± 1.1 μmol/g dry weight/min -DCA v 29.7 ± 2.0 μmol/g dry weight/min +DCA). PDHt was not different between controls and DCA-treated groups. These data indicate that activation of myocardial PDH by adding DCA to retransfused blood improved heart function and metabolism after severe hemorrhagic shock.

KW - DCA

KW - Dichloroacetate

KW - Energy metabolism

KW - Hemorrhage

KW - Hemorrhagic shock

KW - Lactic acid

KW - PDH

KW - Pyruvate dehydrogenase

KW - Resuscitation

KW - Shock

UR - http://www.scopus.com/inward/record.url?scp=0031239286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031239286&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1997.0483

DO - 10.1006/jmcc.1997.0483

M3 - Article

C2 - 9299369

AN - SCOPUS:0031239286

VL - 29

SP - 2465

EP - 2474

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 9

ER -